WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1999007359) USE OF CHOLINESTERASE INHIBITORS FOR TREATING ATTENTION DEFICIT DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1999/007359    International Application No.:    PCT/GB1998/002378
Publication Date: 18.02.1999 International Filing Date: 07.08.1998
Chapter 2 Demand Filed:    02.03.1999    
IPC:
A61K 31/27 (2006.01), A61K 31/407 (2006.01), A61K 31/435 (2006.01), A61K 31/4425 (2006.01), A61K 31/445 (2006.01), A61K 31/55 (2006.01)
Applicants: SHIRE INTERNATIONAL LICENSING B.V. [NL/NL]; Frederiksplein 42 NL-1017 XN Amsterdam (NL) (AL, AM, AT, AU, AZ, BA, BB, BE, BF, BG, BJ, BR, BY, CA, CF, CG, CH, CI, CM, CN, CU, CY, CZ, DE, DK, EE, ES, FI, FR, GA, GB, GE, GH, GM, GN, GR, GW, HR, HU, ID, IE, IL, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MC, MD, MG, MK, ML, MN, MR, MW, MX, NE, NL, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, SN, SZ, TD, TG, TJ, TM, TR, TT, UA, UG, UZ, VN, YU, ZW only).
SNORRASON, Ernir [IS/IS]; (IS).
MURRAY, James, Robert [GB/GB]; (GB) (For US Only)
Inventors: SNORRASON, Ernir; (IS).
MURRAY, James, Robert; (GB)
Agent: GRANT, Anne, Rosemary; Frank B. Dehn & Co. 179 Queen Victoria Street London EC4V 4EL (GB)
Priority Data:
9716879.3 08.08.1997 GB
Title (EN) USE OF CHOLINESTERASE INHIBITORS FOR TREATING ATTENTION DEFICIT DISORDERS
(FR) UTILISATION D'INHIBITEURS DE CHOLINESTERASE DANS LE TRAITEMENT DES TROUBLES DEFICITAIRES DE L'ATTENTION
Abstract: front page image
(EN)The invention provides the use of cholinesterase inhibitors, particularly acetylcholinesterase inhibitors such as galantamine, in the manufacture of a medicament for combatting attention deficit disorders.
(FR)L'invention concerne l'utilisation d'inhibiteurs de cholinestérase, en particulier d'inhibiteurs d'acétylcholinestérase tels que la galantamine, dans la préparation d'un médicament destiné à combattre les troubles déficitaires de l'attention.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, HR, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)